G6420, G6421, G6422, G6430, G6431, G6560, G6570, G6550 For Research Use Only. Not for Use in Diagnostic Procedures.
Patents - Disclaimers
G6420, G6421, G6422, G6430, G6431, G6550 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.
G6420, G6421, G6422, G6430, G6431, G6550 U.S. Pat. No. 8,632,992 and other patents pending.
G6420, G6421, G6422, G6430, G6431, G6550 Promega has a non-exclusive, worldwide license to U.S. Pat. Nos. 7,033,778, 7,256,013, Europe Pat. No. 1243568 and Japan Pat. No. 4267043 and related applications to manufacture, have manufactured, use, possess, distribute, market, sell, offer for sale, and import deacetylase activity assay kits and related products for research and laboratory use (including the use on human derived cell lines, but excluding such use on human subjects for diagnostic or therapeutic purposes), product control, process control, product development and process development.
Furthermore, the rights above are extended to purchasers of licensed products from Promega to use, possess, distribute, market and sell such licensed products for the same purposes and for the same scope as granted to Promega.
G6420, G6421, G6422, G6430, G6431, G6550 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.